Chemistry:3-Fluoromethcathinone
From HandWiki
Short description: Designer stimulant drug
 | |
| Clinical data | |
|---|---|
| Other names | 3-FMC, 3- Fluoromethcathinone |
| Routes of administration | Oral, intranasal, intravenous |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C10H12FNO |
| Molar mass | 181.210 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
3-Fluoromethcathinone (also known as 3-FMC) is a chemical compound of the phenethylamine, amphetamine, and cathinone classes that has been sold online as a designer drug.[1][2] It is a structural isomer of flephedrone (4-fluoromethcathinone).
3-Fluoroisomethcathinone is produced as a by-product when 3-FMC is synthesized, the activity of this compound is unknown.[3]
Effects
This chemical's effects and safety have not been studied scientifically.[3]
Legal status
In the United States, 3-FMC is Schedule I controlled substance.[4]
In the United Kingdom, 3-FMC is a controlled drug under the cathinone blanket ban.
3-FMC is an Anlage II controlled drug in Germany.
3-FMC is banned in the Czech Republic.[5]
See also
- 3,5-Difluoromethcathinone
- 3-Fluoroamphetamine
- 3-Fluoroethamphetamine
- 3-Fluoromethamphetamine
- Substituted cathinone
References
- ↑ "Analysis of Amphetamine-Derived Designer Drugs by Gas Chromatography with Mass Spectrometry". Journal of Analytical Toxicology 40 (1): 78–85. October 2015. doi:10.1093/jat/bkv113. PMID 26446487.
- ↑ "Fluoromethcathinone, a new substance of abuse". Forensic Science International 185 (1–3): 10–20. March 2009. doi:10.1016/j.forsciint.2008.11.013. PMID 19195800.
- ↑ 3.0 3.1 Two cases of confirmed ingestion of the novel designer compounds: 4-methylmethcathinone (Mephedrone) and 3-fluoromethcathinone Susannah Davies et al.
- ↑ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
- ↑ "Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" (in Czech). Ministerstvo zdravotnictví. http://www.mzcr.cz/Admin/_upload/files/3/Nov%C3%A9%20PL.pdf.
 |  |
